142 related articles for article (PubMed ID: 33675448)
1. Effect of a pocket compression device on hematomas, skin reactions, and comfort in patients receiving a cardiovascular implantable electronic device: a randomized controlled trial.
Hu J; Zheng J; Liu X; Li G; Xiao X
J Interv Card Electrophysiol; 2022 Mar; 63(2):275-281. PubMed ID: 33675448
[TBL] [Abstract][Full Text] [Related]
2. Effect of a Novel Pocket Compression Device on Hematomas Following Cardiac Electronic Device Implantation in Patients Receiving Direct Oral Anticoagulants.
Fei YP; Wang L; Zhu CY; Sun JC; Hu HL; Zhai CL; He CJ
Front Cardiovasc Med; 2022; 9():817453. PubMed ID: 35282349
[TBL] [Abstract][Full Text] [Related]
3. Current strategies to minimize postoperative hematoma formation in patients undergoing cardiac implantable electronic device implantation: A review.
Mehta NK; Doerr K; Skipper A; Rojas-Pena E; Dixon S; Haines DE
Heart Rhythm; 2021 Apr; 18(4):641-650. PubMed ID: 33242669
[TBL] [Abstract][Full Text] [Related]
4. Local gentamicin-collagen sponge reduces cardiovascular implantable electronic device infections and pocket hematoma.
Monaco C; Barone L; Cammalleri V; Stifano G; Magliano G; Geuna F; Romeo F; Sergi D
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5218-5224. PubMed ID: 35916820
[TBL] [Abstract][Full Text] [Related]
5. Use of a pocket compression device for the prevention and treatment of pocket hematoma after pacemaker and defibrillator implantation (STOP-HEMATOMA-I).
Turagam MK; Nagarajan DV; Bartus K; Makkar A; Swarup V
J Interv Card Electrophysiol; 2017 Aug; 49(2):197-204. PubMed ID: 28413854
[TBL] [Abstract][Full Text] [Related]
6. Pocket related complications following cardiac electronic device implantation in patients receiving anticoagulation and/or dual antiplatelet therapy: prospective evaluation of different preventive strategies.
Awada H; Geller JC; Brunelli M; Ohlow MA
J Interv Card Electrophysiol; 2019 Apr; 54(3):247-255. PubMed ID: 30460588
[TBL] [Abstract][Full Text] [Related]
7. Novel Compression Tool to Prevent Hematomas and Skin Erosions After Device Implantation.
Kiuchi K; Okajima K; Tanaka N; Yamamoto Y; Sakai N; Kanda G; Shimane A; Yokoi K; Teranishi J; Aoki K; Chimura M; Kono S; Takahashi Y; Matsuyama S; Tsubata H; Miyata T; Matsuoka Y; Toba T; Ohishi S; Sawada T; Tsukishiro Y; Onishi T; Kobayashi S; Moriya F; Takai H; Yamada S; Taniguchi Y; Yasaka Y; Kawai H
Circ J; 2015; 79(8):1727-32. PubMed ID: 25993904
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a novel mechanical compression device for hematoma prevention and wound cosmesis after CIED implantation.
Rojas E; Morgaenko K; Brown L; Kim S; Mazimba S; Malhotra R; Darby A; Monfredi O; Mason P; Mangrum JM; Haines DE; Campbell C; Bilchick K; Mehta NK
Pacing Clin Electrophysiol; 2022 Apr; 45(4):491-498. PubMed ID: 35174901
[TBL] [Abstract][Full Text] [Related]
9. Cardiac implantable electronic device hematomas: Risk factors and effect of prophylactic pressure bandaging.
Koh Y; Bingham NE; Law N; Le D; Mariani JA
Pacing Clin Electrophysiol; 2017 Jul; 40(7):857-867. PubMed ID: 28543543
[TBL] [Abstract][Full Text] [Related]
10. Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysis.
Tarakji KG; Korantzopoulos P; Philippon F; Biffi M; Mittal S; Poole JE; Kennergren C; Lexcen DR; Lande JD; Seshadri S; Wilkoff BL
Heart Rhythm; 2021 Dec; 18(12):2080-2086. PubMed ID: 34280568
[TBL] [Abstract][Full Text] [Related]
11. Randomized Trial of Stand-Alone Use of the Antimicrobial Envelope in High-Risk Cardiac Device Patients.
Ellis CR; Greenspon AJ; Andriulli JA; Gould PA; Carillo RG; Kolek MJ; Donegan R; Amaral AP; Mittal S
Circ Arrhythm Electrophysiol; 2023 May; 16(5):e011740. PubMed ID: 36960716
[TBL] [Abstract][Full Text] [Related]
12. Device implantation for patients on antiplatelets and anticoagulants: Use of suction drain.
Mukherjee SS; Saggu D; Chennapragada S; Yalagudri S; Nair SG; CalamburNarasimhan
Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S389-S393. PubMed ID: 30595295
[TBL] [Abstract][Full Text] [Related]
13. Frequency of "Pocket" Hematoma in Patients Receiving Vitamin K Antagonist and Antiplatelet Therapy at the Time of Pacemaker or Cardioverter Defibrillator Implantation (from the POCKET Study).
Malagù M; Trevisan F; Scalone A; Marcantoni L; Sammarco G; Bertini M
Am J Cardiol; 2017 Apr; 119(7):1036-1040. PubMed ID: 28153344
[TBL] [Abstract][Full Text] [Related]
14. Pocket haematoma after cardiac electronic device implantation in patients receiving antiplatelet and anticoagulant treatment: a single-centre experience.
Demir GG; Guler GB; Guler E; Güneş H; Kizilirmak F; Karaca İO; Omaygenç MO; Çakal B; Olgun E; Savur U; Ibisoglu E; Barutçu I; Kiliçaslan F
Acta Cardiol; 2017 Feb; 72(1):47-52. PubMed ID: 28597740
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.
Tarakji KG; Mittal S; Kennergren C; Corey R; Poole JE; Schloss E; Gallastegui J; Pickett RA; Evonich R; Philippon F; McComb JM; Roark SF; Sorrentino D; Sholevar D; Cronin E; Berman B; Riggio D; Biffi M; Khan H; Silver MT; Collier J; Eldadah Z; Wright DJ; Lande JD; Lexcen DR; Cheng A; Wilkoff BL;
N Engl J Med; 2019 May; 380(20):1895-1905. PubMed ID: 30883056
[TBL] [Abstract][Full Text] [Related]
16. Effect of fibrotic capsule debridement during generator replacement on cardiac implantable electronic device infection risk.
Goldenberg GR; Barsheshet A; Bishara J; Kadmon E; Omelchencko A; Strasberg B; Golovchiner G
J Interv Card Electrophysiol; 2020 Jun; 58(1):113-118. PubMed ID: 31227978
[TBL] [Abstract][Full Text] [Related]
17. Use of oxidized regenerated cellulose to prevent pocket hematomas after cardiac electronic device implantation in patients on anticoagulants or dual antiplatelet therapy.
Chia PL; Foo D
Int J Cardiol; 2013 Oct; 168(4):4406-7. PubMed ID: 23706282
[No Abstract] [Full Text] [Related]
18. Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI).
Deharo JC; Sciaraffia E; Leclercq C; Amara W; Doering M; Bongiorni MG; Chen J; Dagres N; Estner H; Larsen TB; Johansen JB; Potpara TS; Proclemer A; Pison L; Brunet C; Blomström-Lundqvist C;
Europace; 2016 May; 18(5):778-84. PubMed ID: 27226497
[TBL] [Abstract][Full Text] [Related]
19. Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma: Combined Analysis of BRUISE CONTROL 1 and 2.
Essebag V; Healey JS; Joza J; Nery PB; Kalfon E; Leiria TLL; Verma A; Ayala-Paredes F; Coutu B; Sumner GL; Becker G; Philippon F; Eikelboom J; Sandhu RK; Sapp J; Leather R; Yung D; Thibault B; Simpson CS; Ahmad K; Toal S; Sturmer M; Kavanagh K; Crystal E; Wells GA; Krahn AD; Birnie DH
Circ Arrhythm Electrophysiol; 2019 Oct; 12(10):e007545. PubMed ID: 31610718
[TBL] [Abstract][Full Text] [Related]
20. Factors related to the skin thickness of cardiovascular implantable electronic device pockets.
Yatomi A; Takami M; Fukuzawa K; Kiuchi K; Sakai J; Nakamura T; Sonoda Y; Takahara H; Nakasone K; Yamamoto K; Suzuki Y; Tani K; Iwai H; Nakanishi Y; Hirata KI
J Cardiovasc Electrophysiol; 2022 Aug; 33(8):1847-1856. PubMed ID: 35761749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
